Federated Hermes
SCLN

Federated Hermes’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Federated Hermes’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-36,998
Closed -$257K – 2204
2015
Q3 		$257K Buy
36,998
+5,753
+18% +$49.3K ﹤0.01% 1449
2015
Q2 		$307K Sell
31,245
-113,297
-78% -$1.03M ﹤0.01% 1431
2015
Q1 		$1.28M Buy
144,542
+18,280
+14% +$146K ﹤0.01% 1102
2014
Q4 		$1.11M Buy
126,262
+112,812
+839% +$913K ﹤0.01% 1149
2014
Q3 		$93K Buy
13,450
+11,206
+499% +$67.2K ﹤0.01% 1589
2014
Q2 		$12K Buy
+2,244
New +$10.9K ﹤0.01% 1714

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's SCLN Position: Q4 2015 in Review

Federated Hermes sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2015, closing a stake of 36,998 shares — an estimated $257K sold.

Federated Hermes first reported a position in SCLN in Q2 2014 and held it in 6 quarters. The position peaked at $1.28M in Q1 2015. 133 funds tracked by Wall St. Rank hold SCLN as of Q4 2015.

  • Federated Hermes reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Federated Hermes sold 36,998 Sciclone Pharmaceuticals Inc shares in Q4 2015, an estimated $257K.
  • Federated Hermes first reported a position in Sciclone Pharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
  • Federated Hermes's Sciclone Pharmaceuticals Inc position peaked at $1.28M in Q1 2015.
  • 133 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2015.

Based on Federated Hermes's 13F filing for Q4 2015, filed 12 Feb 2016.